 model updat tri put impli
market valuat perspect lower pt
messag look back april launch time underappreci
evolv competit landscap quickli would impact align growth
trajectori took comfort sizabl pullback share prior six month
adopt view concern discount valuat aftermath
yesterday result tri ration assess algn new invest
paradigm impli valuat base stock indic open
morn take step back revis growth impli valuat may screen
attract rel compar peer group investor potenti appreci
revis estim lower pt
bottom line share heavi pressur yesterday
after-market follow disappoint result forward commentari much
appreci result rais signific warrant concern regard
competit landscap outlook diminish growth go forward
said thought would help tri put post-market impli valuat
perspect given revis outlook new invest paradigm go forward
conced face stiffer competit must also consid industri
still larg under-penetrated sub potenti support multipl player
worth remind still lead compani industri larg scale
first-mov advantag compani top-lin growth appear risk
deceler would suggest mid-teen revenu growth still healthi
context new valuat level moreov respect manag
meaning lower bar expect second half believ could
potenti provid attract exit point come quarter term valuat
share look open rang would impli valuat
revis revenu estim far cri near forward valuat
time last year lost us result significantli disappoint event
re-evalu share aftermath investor may want consid long-term
global penetr opportun lie ahead industri lower estim
reflect revis outlook accordingli reduc pt
lower estim lower revenue/adjust ebitda
estim
previous revis estim impli
revenue/adjust ebitda growth
clear align industri still under-penetrated note global basi clear
align industri still larg under-penetrated offer long runway growth
view analyst day state global ortho market repres
case malocclus per year per region america emea apac
manag state compani technolog serv market
result case suggest even leader
market penetr industri competit landscap
certainli intensifi result embolden concern believ industri
still earlier inning support multipl player healthi growth time
posit lost larg neg print result larg
disappoint posit takeaway worth note first intern volum
growth still gener healthi itero growth also strong
compani continu execut well scanner front addit declin
sequenti world-wide declin relat fx suggest
market may still see stabil price perspect final believ
page analyst certif import disclosur
investor expect meaning reset manag lower
bar significantli creat reason setup remaind
impli valuat rel dental/medtech look reason base
yesterday after-market trade share look potenti open
rang would place valuat ev/revenu ev/ebitda
revis estim comparison averag dental peer trade ev/
ebitda ebitda growth mid-singl digit rang compar algn
averag ebitda growth base revis estim algn mid-cap
medic technolog peer trade ev/revenu revenu growth high singl
digit compar algn averag revenu growth ebitda
basi medic technolog peer trade ev/ebitda ebitda growth
low doubl digit compar algn current valuat ebitda
ebitda growth roughli next three fiscal year appreci
concern around potenti algn growth rate continu deceler
like limit investor confid manag long-term growth target
would suggest current valuat screen attract rel dental
medic technolog peer group believ still pois grow well peer
averag even deceler revis pt assum
revenu roughli ebitda primari risk downsid
potenti intensifi competit landscap impact revenu growth
expect term volum price
page analyst certif import disclosur
valuat risk reduc price target maintain
buy rate new pt base share eventu trade revenu vs
previou target multipl lower multipl reflect recent quarterli
result conserv expect futur growth view primari
risk downsid potenti intensifi competit landscap impact
revenu growth expect term volum price addit
would caution meaning prolong recessionari environ would like
impact compani near-term growth potenti price power
page analyst certif import disclosur
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic
inc next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori inc
creat bluematrix
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/or
cs coverag suspend guggenheim secur llc suspend coverag compani
nc cover guggenheim secur llc cover compani
monitor describ stock whose compani fundament financi monitor financi project opinion
invest merit compani provid
review ur follow releas signific news compani rate temporarili place review suffici
inform obtain assess analyst
guggenheim secur llc methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ restrict analys
market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash flow ev/ebitda price-to-earnings pe/growth
price-to-cf p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
price target assign buy- sell-rat stock price target neutral-r stock provid discret analyst
page analyst certif import disclosur
